JYNT - רווח נקי למניה ב-12 החודשים האחרונים thejoint.com
The Joint Corp. (JYNT) maintains its leadership in manual therapy driven by patient loyalty and service affordability. The trend in rolling annual earnings per share confirms this status, where the 0.20 parameter determines the metric's value. An attractive, bureaucracy-free physician partnership model and independence from macroeconomic shifts transform the company into a reliable defensive asset with sustainable demand.
%20%D7%A8%D7%95%D7%95%D7%97%20%D7%9C%D7%9E%D7%A0%D7%99%D7%94%20%D7%91%D7%90%D7%A8%D7%91%D7%A2%D7%AA%20%D7%94%D7%A8%D7%91%D7%A2%D7%95%D7%A0%D7%99%D7%9D%20%D7%94%D7%90%D7%97%D7%A8%D7%95%D7%A0%D7%99%D7%9D&width=1200&height=400&colorIndex=0&v=mwczyyub.rjb-7czcsu8&start=20220704&end=20261112&filename=GURU_Markets_-_JYNT_-_The-Joint-Corp._-_Earnings-per-share-for-the-last-four-quarters "The Joint - רווח נקי למניה (EPS TTM) JYNT (תקופה 04.07.2022 - 12.11.2026) | 👁️GURU.Markets👁️")
פילוחים אנליטיים של חברת The Joint Corp (JYNT)
Analyzing the net income per share over the last 12 months allows for an assessment of the scaling efficiency of The Joint Corp. (JYNT), which attracts therapists through a lack of bureaucracy and a steady stream of clients. This metric measures the actual return per share, enabling investors to promptly detect a slowdown in capital efficiency, which, amid high demand for the asset, could trigger a sharp decline in share prices.
